QuidelOrtho Corporation (NASDAQ:QDEL) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET
Company Participants
Brian J. Blaser – President, CEO & Director
Joseph M. Busky – Chief Financial Officer
Juliet C. Cunningham – Vice President of Investor Relations
Conference Call Participants
Andrew Harris Cooper – Raymond James & Associates, Inc., Research Division
Casey Rene Woodring – JPMorgan Chase & Co, Research Division
Conor Noel McNamara – RBC Capital Markets, Research Division
Jack Meehan – Nephron Research LLC
Jack Melick – Jefferies LLC, Research Division
Lu Li – UBS Investment Bank, Research Division
Margarate Elizabeth Boeye – William Blair & Company L.L.C., Research Division
Patrick Bernard Donnelly – Citigroup Inc., Research Division
Operator
Welcome to the QuidelOrtho Second Quarter 2025 Financial Results Conference Call and Webcast. [Operator Instructions] Please note, this conference call is being recorded. An audio replay of this conference call will be available on the company’s webcast shortly after this call.
I would now like to turn the call over to Juliet Cunningham, the Vice President of Investor Relations. Please proceed.
Juliet C. Cunningham
Thank you. Good afternoon, everyone, and thanks for joining the QuidelOrtho Second Quarter 2025 Financial Results Conference Call. Joining me today are Brian Blaser, President and Chief Executive Officer; and Joe Busky, Chief Financial Officer. This conference call is being simultaneously webcast on the Investor Relations page of our website. To aid in the presentation, we have also posted supplemental information on the Investor Relations page that will be referenced throughout this call.
This conference call and supplemental information contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historically — strictly historical, including the company’s expectations, plans, financial guidance and future performance as well as prospects are forward-looking statements that are subject to certain risks, uncertainties, assumptions and other factors. This
#QuidelOrtho #Corporation #QDEL #Earnings #Call #Transcript